Search our Available Technologies
By Clinical Application > Blood & Lymphatic Disease
A method of determining resistance of a blood cancer to PI3K inhibitors as well as treating blood cancers
Unmet Need Lymphomas are highly diverse and among the most...
MORE >MEK inhibitors as therapeutic agents and diagnostic tools for hemoglobinopathies, including thalassemia
Value Proposition Patients with sickle cell disease experience acute vaso-occlusive...
MORE >G protein-coupled receptor kinase 2 and beta arrestins as therapeutic targets and diagnostic tools for hemoglobinopathies
Value Proposition Sickle cell disease affects millions of people throughout...
MORE >RNA Aptamers Targeting a coagulation Cascade Cofactor
Value Proposition Thrombosis (blood clots within blood vessels) is a...
MORE >RNA aptamers for thrombi imaging
Value Proposition Thrombosis (blood clots within blood vessels) is a...
MORE >Aptamers to Glycoprotein VI
Value Proposition Millions of Americans have received antiplatelet agents to...
MORE >Controlling coagulation with aptamer combinations and aptamer-drug combinations and their antidotes
Value Proposition Millions of Americans have received anticoagulative agents to...
MORE >